Why is Alvotech ?
- Poor long term growth as Net Sales has grown by an annual rate of 256.02% and Operating profit at 37.21% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -7.56
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -68.96%, its profits have risen by 77% ; the PEG ratio of the company is 0.5
- Along with generating -68.96% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Alvotech for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD -26.49 MM
At USD 419.75 MM has Grown at 33.65%
Lowest at -701.12 %
Fallen by -13.12% (YoY
Highest at 4.26 times
At USD -6.09 MM has Grown at 75.41%
At USD -5.25 MM has Grown at 53.9%
At USD 26.79 MM has Grown at -50.24%
Lowest at 1.53 times
Lowest at USD 11.48 MM
Lowest at 10.09 %
Here's what is working for Alvotech
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Net Sales (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales
Depreciation (USD MM)
Here's what is not working for Alvotech
Operating Profit (USD MM)
Operating Profit to Sales
Inventory Turnover Ratio






